Table 1 Investigations before and after treatment
Investigations (normal range) | Before treatment | After 5 months of treatment |
|---|---|---|
ESR in the first hour | Over 100 mm | 22 mm |
CRP (0−5) | 36 mg/L | 4.1 mg/L |
CPK (33−211) | 12970 U/L | 254 U/L |
CK-MB (0−5) | 179 ng/ml | 30.3 ng/ml |
Troponin (0−0.04) | 5 μg/L | 0.04 μg/L |
ALT (0−33) | 490 U/L | 49 U/L |
AST (0−32) | 373 U/L | 37 U/L |
Aldolase (1−7.5) | 30.5 U/L | 9.5 U/L |
LDH (140−280) | 1231 U/L | 190 U/L |
Ferritin (24−300) | 2376 ng/mL | 150 ng/mL |
Albumin (3.5−5.5) | 2.6 g/dL | 3.9 g/dL |
HB (11.5−15.5) | 10.9 g/dl | 12.4 g/dl |
TLC (4−11) | 19.02 thousand/cmm | 7.2 thousand/cmm |
Platelets (150−450) | 582 thousand/cmm | 264 thousand/cmm |
Total cholesterol (up to 200) | 207 mg/dL | 153 mg/dL |
Serum triglycerides (0−150) | 173 mg/dL | 150 mg/dL |
HDL cholesterol (40−60) | 37 mg/dL | 29 mg/dL |
LDL cholesterol (0−100) | 135 mg/dL | 69 mg/dL |